Trevi Therapeutics Cash from Financing (TTM) Insights

Trevi Therapeutics Inc (TRVI)

2.54 -0.11 (-4.15%) USD | NASDAQ | Apr 25, 16:00

2.56 +0.02 (+0.79%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2018. Upgrade now.

Date	Value
December 31, 2023	-7.91M
September 30, 2023	-7.204M
June 30, 2023	46.59M
March 31, 2023	110.23M
December 31, 2022	111.31M
September 30, 2022	124.40M
June 30, 2022	69.23M
March 31, 2022	16.00M
December 31, 2021	20.78M
September 30, 2021	7.671M
June 30, 2021	23.63M

Date	Value
March 31, 2021	20.87M
December 31, 2020	16.72M
September 30, 2020	16.08M
June 30, 2020	-0.15M
March 31, 2020	63.36M
December 31, 2019	73.21M
September 30, 2019	71.70M
June 30, 2019	82.31M
March 31, 2019	15.53M
December 31, 2018	3.629M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-7.91M

Minimum

Dec 2023

124.40M

Maximum

Sep 2022

45.20M

Average

23.63M

Median

Jun 2021

Cash from Financing (TTM) Benchmarks